According to a new study, risk of developing breast cancer can be predicted by measuring high bone mineral density (BMD) regardless to how high risk is on frequently used Gail model.
To better predict the risk of breast cancer, the two measurements would be used together in tandem, the researchers stated.

It is expected that the findings will be published in the Sept.1 issue of the journal Cancer and it will follow the foot steps of those other researches related to different aspects of breast cancer risk with bone health.

In May, a study that was presented at the American Society of Clinical Oncology showed that Zometa which was used to treat osteoporosis could decrease the risk of recurrence of breast cancer in premenopausal women.

Similarly, another study that has been recently released shows if the women with breast cancer have vitamin D deficiency at the time of diagnosis of the disease, their chances of recurrence of the disease and death are quite higher.  Vitamin D is considered essential for healthy bones.
The researchers from the University of Arizona, Tucson, led the study and they incorporated hip BMD information and Gail scores of those 10,000 postmenopausal women who were taking part in the Women’s Health Initiative.
With an average nine years of follow-up, the chances of developing breast cancer were 35 percent higher in women with increased Gail score and there was a 25 percent high risk of developing breast cancer with the increase of each unit in total hip BMD.
Women with the highest BMD and Gail scores had a particularly high risk of developing cancer.
This article is the property of http://www.healthpm.com
Copying and publishing any article from our site is strictly NOT allowed